Evaluation of the Sanitary Safety of a Healthcare Professional Conference Held 9-11 June 2021 in Paris

Covid19 Clinical Trial

— COVID-FREE  

Official title:

Evaluation of the Sanitary Safety of the French Intensive Care Society Annual Meeting Held From June 9th to June 11th 2021 at the Paris Congress Centre

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04918160
• Other study ID #: 2021-A01185-36
• Status: Completed
• Start date: June 8, 2021
• Est. completion date: July 2, 2021

Study information

• Verified date: October 2021
• Source: French Society for Intensive Care
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The COVID-SRLF study will evaluate the sanitary safety of the French Intensive Care Society (FICS) annual meeting held in Paris Congress Center from June 9th to June 11th 2021 in the Coronavirus Disease 2019 (COVID-2019) pandemic situation. The primary objective is to determine the proportion of attendees with a positive antigenic COVID-19 screening test at day 7 (+/- 1) of their participation to the meeting. This rate will be compared to a cohort of health care professionals (medical doctors and paramedical professionals) from the same hospital ward as the attendees but who did not attend the meeting (stratified on centers, gender, age (< and >= 40 years, vaccination status (0, 1 or 2 doses) and socio-professional status (medical doctor, nurse, nurse assistant).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 711
• Est. completion date: July 2, 2021
• Est. primary completion date: July 2, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Healthcare professional healthy volunteer

• Absence of COVID-19 symptoms in the 2 weeks prior to inclusion

• Not being a COVID-19 contact case in the 2 weeks prior to inclusion

• Participation to at least one day of the FICS annual meeting (June 9-11 2021)

Exclusion Criteria:

• Non-healthcare professional (exhibitors, congress center employees)

• Refusal to participate to the study

• Person under legal protection

• Absence of social security affiliation

Related Conditions & MeSH terms

• COVID-19
• Covid19

Intervention

Other:
• Exposure to the FICS annual meeting (June 9-11 2021, Paris Congress Center)
The study will compare COVID-19 screening nasal antigenic self-test (Boiron Auto Test Covid Nasal) positivity at D7 and COVID-19 symptoms in the 21 days between participants to the FICS annual meeting held in June 9-11 2021 in the Paris Congress Center (conference attendees / exposed) and healthcare professionals who did not attend the meeting (controls / not exposed).

Locations

Country	Name	City	State
France	Centre des Congres	Paris

Sponsors (1)

Lead Sponsor	Collaborator
French Society for Intensive Care

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Conference attendees COVID-19 prevalence at D7	Proportion of conference attendees with a positive COVID-19 autotest at day 7 of the last day of the meeting (June 18th, 2021).	Day 7 of the last day of the meeting (June 18th, 2021)
Secondary	Controls COVID-19 prevalence at D7	Proportion of controls (healthcare professional not participating to the conference) with a positive COVID-19 autotest at day 7 of the last day of the meeting (June 18th, 2021).	Day 7 of the last day of the meeting (June 18th, 2021)
Secondary	Proportion of conference attendees with COVID-19 symptoms at D21	Proportion of conference attendees reporting COVID-19 compatible symptoms until day 21 of the last day of the congress (July 2, 2021).	Day 21 of the last day of the congress (July 2, 2021)
Secondary	Proportion of conference attendees with COVID-19-related medical consultation at D21	Proportion of conference attendees reporting COVID-19-related medical consultation until day 21 of the last day of the congress (July 2, 2021).	Day 21 of the last day of the congress (July 2, 2021)
Secondary	Proportion of conference attendees with COVID-19-related emergency department visit at D21	Proportion of conference attendees reporting COVID-19-related emergency department visit until day 21 of the last day of the congress (July 2, 2021).	Day 21 of the last day of the congress (July 2, 2021)
Secondary	Proportion of conference attendees with COVID-19-related hospitalisation at D21	Proportion of conference attendees reporting COVID-19-related hospitalisation until day 21 of the last day of the congress (July 2, 2021).	Day 21 of the last day of the congress (July 2, 2021)